In a previous article, we explored Yu Wenhong, a medical aesthetics figure known for “high-end anti-aging,” and the mystery surrounding her “blood rejuvenation therapy.” In a video, she pitched to wealthy clients a so-called “revolutionary technique” that supposedly reverses aging: extracting extracellular vesicles and functional proteins from 17–21-year-old young men and injecting them into middle-aged and elderly clients for rapid rejuvenation.
Although the video has been removed from Douyin (TikTok China), it was still widely circulated on X as of Nov. 14. In the leaked footage, Yu Wenhong casually stated that Europe already has popular anti-aging therapies involving the “infusion of young blood,” and that her team’s technology goes further: they can extract the “vesicles” and “youth proteins” found only in young men.
She claimed that:
- Only one doctor in China knows this technique.
- Her team “monopolizes” the technology.
- It can only be used at their “Pengruili Hospital.”
- The effects are immediate: within one to two weeks, it boosts male sexual function, delays aging, and makes patients at least a decade younger.
But the biggest question among viewers is: where does the blood come from?
In the video, Yu Wenhong stated that she controls a “blood products listed company worth over 100 billion yuan,” which is “the only company authorized to buy blood” and has approval from the Chinese Ministry of Health (now the National Health Commission).
Success
You are now signed up for our newsletter
Success
Check your email to complete sign up
In other words, she claimed to have official permission and legal channels to obtain large quantities of young male blood.
However, China’s legal blood donation system clearly stipulates:
- Blood cannot be bought or sold.
- Donations are voluntary.
- Blood is not collected according to age or sex, and certainly not limited to 17–21-year-old males.
So, if her claims are true — a stable, large supply of blood for extracting vesicles, sourced specifically from young men — then what is behind it? Is it certain donor groups, specific hospitals, special channels, or something even more disturbing?
All of this suggests that the blood source is unusual, even chilling.
Who exactly authorized this ‘legality’?
Yu Wenhong emphasized that she has a listed blood company, official approvals, and that the technology is “absolutely legal.” Yet Chinese law has no provisions allowing transfusions for anti-aging or rejuvenation purposes, nor any system permitting medical institutions to extract and sell vesicles from specific groups. Blood companies typically produce plasma products, not “youth blood anti-aging therapies.” This effectively disguises an illegal and ethically dubious practice as “legally sanctioned.”
Shockingly, she openly named two major shareholders:
- Kuok Hock Nien (郭鹤年), Malaysia’s richest man, under whose “Pengruili Group,” her hospital, is named.
- Haier Group, which she claims is another major shareholder.
If true, this would be a staggering revelation.
Why is this so alarming?
It exposes three realities:
- China’s medical aesthetics industry has already slipped into a “grey zone of human experimentation.”
- The enormous market demand for anti-aging leads some to trade money for “biological rejuvenation.”
- Blood sourcing is extremely opaque.
If “youth blood” truly exists in large amounts, it may involve:
- Targeted donor groups,
- Internal flows within medical institutions,
- Young men, students, or migrant workers being silently collected,
- Or even illegal blood purchases.
A horrifying revelation from Southeast Asia:
A blogger who infiltrated scam centers in Southeast Asia recently exposed an astonishing truth: the “youth blood” claimed by Yu Wenhong is allegedly linked to the illegal extraction of baby stem cells.
The blogger revealed:
- Scam centers are not just about phone or online fraud; the real profit comes from trafficking babies, artificial pregnancies, and harvesting infant stem cells for “rejuvenation blood.”
- Women over 40 lured to these centers are forced into artificial pregnancies, sometimes carrying two or three embryos at once to maximize “supply.”
- Infants are turned into commodities: kept in incubators to extract cord blood, stem cells, growth factors, which are the most expensive materials on the black market.
Prices are staggering:
- One vial of extracted material = 5 million RMB
- Processed into three “rejuvenation treatments,” each sold for 15 million RMB
- One infant extraction = 45 million RMB
Babies aged 0–6 months are considered “ideal raw materials” because they do not resist and are easily controlled.
Why infants?
Because they are more profitable than adult organs:
- Adult organ black market: ~$100,000–150,000, high risk, high cost
- Infant materials: low cost (feeding only), no resistance, high demand, fast turnover
Where does it go?
The extracted materials enter the black-market “rejuvenation blood” industry across China and Southeast Asia, sold to wealthy clients for anti-aging treatments costing tens of millions, including:
- “Rejuvenation blood,”
- “Youth plasma,”
- “Stem cell growth factor therapies.”
Over a decade ago, insiders reportedly exposed similar operations in Beijing, where women were forced to continuously give birth for material extraction. The scam centers in Southeast Asia are just a modern replication, now more professional and commercialized.
The article represents the author’s personal views and does not necessarily reflect the views of Vision Times.
